Clinical trials
Phase 2 Behcet Syndrome trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 7 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 4 |
| Terminated | 4 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liu Tian | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Novartis Pharmaceuticals | 2 |
| Peking Union Medical College Hospital | 2 |
| Peking University People's Hospital | 2 |
| Tehran University of Medical Sciences | 2 |
| Wenjie Zheng | 2 |
| Amgen | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| HeJing | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Behcet Syndrome | 25 |
| Uveitis | 5 |
| Retinal Vasculitis | 3 |
| Immunoglobulin G4-Related Disease | 2 |
| Inflammation | 2 |
| Lupus Erythematosus, Systemic | 2 |
| Myositis | 2 |
| Scleroderma, Systemic | 2 |
| Aneurysm | 1 |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 |
Trials
Showing 76 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.